Related Experiment Video
Updated: Jun 21, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation
Kush Patel1, Wayne J G Hellstrom
1Tulane University, Department of Urology, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Abstract:
Premature ejaculation (PE) is characterized by a short ejaculatory latency time, poor control over ejaculation and a negative impact on quality of life. The process of ejaculation is under central control, and serotonin (5-HT) is a key mediator; therefore, SSRIs and tricyclic antidepressants, including paroxetine, sertraline and clomipramine, are commonly used with chronic daily dosing in the treatment of PE. Dapoxetine, a short-acting SSRI that acts supraspinally to inhibit ejaculation, has been approved in several European countries for on-demand treatment of PE. With a range of centrally acting treatment options, treatment should be tailored to meet the needs and preferences of individual patients.
Related Concept Videos
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...